인쇄하기
취소
|
Will the unfortunate osteoporosis treatment, ‘Forsteo(teriparatide)’ succeed in getting the health insurance benefit?
Since Lilly, a supplier of Forsteo, has taken the re-deliberation process, the government is currently reviewing the registration of the benefit once again.
Forsteo is a drug which failed a number of attempts to be registered for the benefit from 2006 to the last year’s August...